Recombinant Human LILRB1/CD85j/ILT2 His Biotin Protein, CF Summary
Gly24-His458, with a C-terminal 6-His tag
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
|Formulation||Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.|
|Reconstitution||Reconstitute at 500 μg/mL in PBS.|
|Shipping||The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.|
|Stability & Storage:||Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
When Human LILRB1/CD85j/ILT2 Antibody (MAB20172) is immobilized at 0.2 µg/mL (100 µL/well), Biotinylated Recombinant Human LILRB1/CD85j/ILT2 His-tag Protein (Catalog # BT8989) binds with an ED50 of 1.00-15.0 ng/mL.
2 μg/lane of Recombinant Human LILRB1/CD85j/ILT2 His-tag Biotinylated Protein (Catalog # BT8989) was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie® Blue staining, showing bands at 68-79 kDa.
LILRB1, also known as CD85j and ILT2, is a 110 kDa transmembrane glycoprotein in the LILR immunoregulatory protein family (1). Mature human LILRB1 consists of a 438 amino acid (aa) extracellular domain (ECD) with 4 tandem Ig-like domains, a 21 aa transmembrane segment, and a 168 aa cytoplasmic domain with 4 inhibitory ITIM motifs (2). Alternative splicing generates an additional isoform that lacks the transmembrane and cytoplasmic regions (3). LILRB1 is expressed on the surface of B cells and monocytes, as well as subsets of NK cells, memory/effector CD8+ T cells, gamma δ T cells, and monocyte-derived dendritic cells (3-7). LILRB1 binds to MHC-I as well as non-classical MHC-I molecules (e.g. HLA-F, HLA-G, and HLA-B27) and the MHC-I mimetic UL18 encoded by cytomegalovirus (3, 5, 8-10). R&D Systems in-house testing indicates that LILRB1 also binds to Angiopoietin-like 7. Ligation of LILRB1 inhibits the antigen induced proliferation and activation of CD8+ T cells, CD4+ T cells, NK cells, and gamma δ T cells (3, 4, 11-13). On dendritic cells, ligation inhibits the production of IL-10, IL-12p70, and TGF-beta and protects from Fas-mediated apoptosis (7).
- Thomas, R. et al. (2010) Clin. Rev. Allergy Immunol. 38:159.
- Samaridis, J. and M. Colonna (1997) Eur. J. Immunol. 27:660.
- Colonna, M. et al. (1997) J. Exp. Med. 186:1809.
- Harly, C. et al. (2011) Blood 117:2864.
- Cosman, D. et al. (1997) Immunity 7:273.
- Young, N.T. et al. (2001) J. Immunol. 166:3933.
- Young, N.T. et al. (2008) Blood 111:3090.
- Lepin, E.J.M. et al. (2000) Eur. J. Immunol. 30:3552.
- Shiroishi, M. et al. (2003) Proc. Natl. Acad. Sci. USA 100:8856.
- Allen, R.L. et al. (2001) J. Immunol. 167:5543.
- Ince, M.N. et al. (2004) Immunology 112:531.
- Saverino, D. et al. (2000) J. Immunol. 165:3742.
- Saverino, D. et al. (2002) J. Immunol. 168:207.
No product specific FAQs exist for this product, however you mayView all Proteins and Enzyme FAQs
Supplemental Cell Selection Products
Supplemental ELISA Products
Reviews for Recombinant Human LILRB1/CD85j/ILT2 His Biotin Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Human LILRB1/CD85j/ILT2 His Biotin Protein, CF and earn rewards!
Have you used Recombinant Human LILRB1/CD85j/ILT2 His Biotin Protein, CF?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image